Real‐world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records

Abstract

Overall, dupilumab was well-tolerated and resulted in clinical improvement in our patient population. These results provide additional important information on the safety and utility of dupilumab treatment for moderate to severe atopic dermatitis in the real-world clinical setting.